Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection

Infection and Immunity

Volumn 70, Issue 10, 2002, Pages 5547-5555

  Garg, Nisha ^a   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; PLASMID DNA; SIALIDASE; VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVITY; CELL ASSAY; CHAGAS DISEASE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GENETIC CODE; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFLAMMATION; LETHALITY; METHODOLOGY; MORTALITY; MOUSE; MULTIGENE FAMILY; NONHUMAN; PARASITISM; PLASMID; PRIORITY JOURNAL; PROTOZOAL INFECTION; PROVOCATION TEST; SKELETAL MUSCLE; T LYMPHOCYTE; TISSUE INJURY; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; BASE SEQUENCE; CHAGAS DISEASE; COS CELLS; DNA, PROTOZOAN; FEMALE; GENES, PROTOZOAN; GLYCOPROTEINS; IMMUNIZATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEURAMINIDASE; PROTOZOAN VACCINES; T-LYMPHOCYTES, CYTOTOXIC; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 0036785658     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.10.5547-5555.2002     Document Type: Article

References (51)

1. Specific cellular and humoral immune response in BALB/c mice immunized with an expression genomic library of Trypanosoma cruzi
2. IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response
3. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease
4. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice
5. Designer vaccines for parasitic diseases
6. DNA vaccines
7. DNA-based vaccines against malaria: Status and promise of the Multi-Stage Malaria DNA Vaccine Operation
8. Effective DNA vaccination against listeriosis by prime/boost inoculation with the gene gun
9. Nucleotide sequence and transcription of a trypomastigote surface antigen gene of Trypanosoma cruzi
10. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi
11. + T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene
12. Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: Suppressive effects of IL-12 boost are mediated by nitric oxide
13. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner
14. Malaria DNA vaccines in Aotus monkeys
15. Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis
16. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV
17. + T-cell function to immune control of Trypanosoma cruzi
18. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases
19. + cytotoxic T lymphocytes
20. Molecular cloning of the gene encoding the 83-kDa amastigote surface protein and its identification as a member of the Trypanosoma cruzi sialidase superfamily
21. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: Identification of A2-restricted epitopes
22. Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA
23. Chagas' disease: Epidemiology and prospects for interruption of transmission in the Americas
24. Amastigote and epimastigote stage-specific components of Trypanosoma cruzi characterized by using monoclonal antibodies
25. Modulation of immune responses to DNA vaccines by codelivery of cytokine genes
26. Protective immune responses induced by vaccination with an expression genomic library of Leishmania major
27. DNA immunization with Topanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection
28. Antigenic polymorphism of Trypanosoma cruzi: Clonal analysis of trypomastigote surface antigens
29. Measurement of cytolytic antibody in experimental Chagas' disease using a terminal radio-labeling procedure
30. Predominance of CD4 Th1 and CD8 Tc1 cells revealed by characterization of the cellular immune response generated by immunization with a DNA vaccine containing a Trypanosoma cruzi gene
31. Exact prediction of a natural T-cell epitope
32. Gene gun-mediated delivery of an interleukin-12 expression plasmid protects against infections with the intracellular protozoan parasites Leishmania major and Trypanosoma cruzi in mice
33. The identification and molecular characterization of Trypanosoma cruzi amastigote surface protein-1, a member of the trans-sialidase gene super-family
34. Pathology of Chagas' disease
35. THe immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy
36. DNA-based immunization with Trypanosoma cruzi complement regulatory protein elicits complement lytic antibodies and confers protection against Trypanosoma cruzi infection
37. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes
38. + T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection
39. Immunity to Trypanosoma cruzi
40. Parasite persistence in the aetiology of Chagas' disease
41. Depletion of T-cell subpopulations results in exacerbation of myocarditis and parasitism in experimental Chagas' disease
42. Chagas' disease etiology: Autoimmunity or parasite persistence?
43. Augmentation of immune responses to hepatitis E virus ORF2 DNA vaccination by codelivery of cytokine genes
44. Genetic immunization with glycoprotein 63 cDNA results in a helper T-cell type 1 immune response and protection in a murine model of leishmaniasis
45. Uses of granulocyte-macrophage colony-stimulating factor in vaccine development
46. Vaccination with trypomastigote surface antigen-1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection
47. + Tc1 responses
48. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses
49. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes
50. Parasite persistence correlates with disease severity and localization in chronic Chagas' disease